Conivaptan Withdrawn Phase 3 Trials for Hyponatremia Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00684164Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients